01/13/2025
6:00 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
6:02 PM | Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:03 PM | Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:04 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:05 PM | Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:06 PM | Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:06 PM | Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
5:12 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:43 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
8:00 PM | Amicus Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G/A | |
11/14/2024
10:37 AM | Amicus Therapeutics (Subject)
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
|
11/14/2024
8:31 AM | Amicus Therapeutics (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Amicus Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/07/2024
4:49 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
4:03 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
6:01 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
5:23 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:49 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
6:00 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
12:24 PM | Amicus Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
| Form SC 13G/A | |
10/04/2024
3:05 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
3:35 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
3:19 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
4:10 PM | Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
6:01 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2024
7:10 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
4:01 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
3:22 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:54 PM | Amicus Therapeutics (Issuer)
WHITMAN BURKE W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:44 PM | Amicus Therapeutics (Issuer)
RAAB MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:46 PM | Amicus Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:47 PM | Amicus Therapeutics (Issuer)
Kelly Michael Aaron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:49 PM | Amicus Therapeutics (Issuer)
Bleil Lynn Dorsey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:52 PM | Amicus Therapeutics (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:53 PM | Amicus Therapeutics (Issuer)
WHEELER CRAIG A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:41 PM | Amicus Therapeutics (Issuer)
MCGLYNN MARGARET G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:38 PM | Amicus Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/05/2024
3:35 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:00 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
3:31 PM | Amicus Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024
3:32 PM | Amicus Therapeutics (Filer)
| Form DEFA14A | |
Do this Before Elon’s Reveal on January 22nd (Ad) Elon’s newest tech could pay you an extra $30,000 a year — while you sleep.
It’s smaller than a quarter but designed to power a $9 trillion AI revolution.
And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. |
04/16/2024
4:42 PM | Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
3:27 PM | Amicus Therapeutics (Subject)
Crowley John F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
5:14 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
4:52 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
6:12 PM | Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
| Form 4/A | |
03/15/2024
6:13 PM | Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
| Form 4/A | |
03/15/2024
6:14 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4/A | |
03/15/2024
6:15 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4/A | |
03/15/2024
6:10 PM | Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
| Form 4/A | |
03/11/2024
4:36 PM | Amicus Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:21 PM | Amicus Therapeutics (Issuer)
MCGLYNN MARGARET G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:22 PM | Amicus Therapeutics (Issuer)
RAAB MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:35 PM | Amicus Therapeutics (Subject)
MCGLYNN MARGARET G (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
3:39 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
3:33 PM | Amicus Therapeutics (Subject)
Crowley John F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
6:02 AM | Amicus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
4:21 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:23 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:19 PM | Amicus Therapeutics (Subject)
Clark David Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024
3:19 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
8:22 AM | Amicus Therapeutics (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
02/08/2024
3:40 PM | Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:22 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:22 PM | Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
3:44 PM | Amicus Therapeutics (Subject)
Crowley John F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
3:45 PM | Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024
4:20 PM | Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
3:18 PM | Amicus Therapeutics (Subject)
Crowley John F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
